John D. Yee
CIK: 0001926290
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TPST
Tempest Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Yee John D.
Yee John D. (SEC CIK 0001926290) files insider reports with the SEC as Director of Tempest Therapeutics, Inc. (TPST).
Signal8 holds 2 ownership filings by Yee John D. (1 Form 3, 1 Form 4), filed on Jun 17, 2026. Those filings report 1 transaction, the latest on Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Yee John D.'s filings is in LINCOLN, MA.
Recent filings by Yee John D.
- Jun 4, 2026: Grant or award of TPST derivative securities (Form 4, code A).
Other insiders filing for Tempest Therapeutics, Inc. (TPST)
- Frederick John W., Director
- Smith Nancy Freda, Director
- Angel Matthew, CEO and President
- Richey William Drake, Director
- Trojanowski Justin, Corporate Controller
- Maestas Nicholas, Chief Financial Officer